Company profile
Stalicla company profile
Stalicla is a clinical stage, precision molecular neuroscience biotech company with a mature pipeline for patients with Neurodevelopmental Disorders (NDDs) and Neuropsychiatric disorders. Stalicla’s unique approach addresses a principal weakness in the drug development process for NDD’s and neuropsychiatric disorders: behavior is a terrible biomarker. Clinical psychiatric and neurodevelopmental diagnoses encompass a broad diversity of underlying biology. This has contributed to drug development failure by diluting true responders in a population of patients with heterogeneous biology.
Business identity
- Website
- https://stalicla.com
- Contact email
- [email protected]
- Phone number
- +41 22-545-12-42
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2017-05-01, Month
Headquarters
- Headquarters
- Hasle, Lucerne, Switzerland
- Postal code
- 1202
- Country code
- CH
- Continent
- Europe